Straumann rises after Q3 sales modestly beat expectations

By Reuters News

** Shares in Swiss dental implants maker Straumann STMN.S rise 2.7% in pre-market indications after Q3 revenue slightly beat expectations driven by all regions

** The company reported Q3 revenue of 667.1 million Swiss francs ($805.1 million) versus a Vara consensus of 662.3 million

** North America sales grew 7.5%, with the broker Vontobel saying the region "performed as expected" and continued its positive trajectory despite a soft demand backdrop

** The group confirmed its full-year outlook

** The stock has gained 4.5% YTD

($1 = 0.8286 Swiss francs)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk